Research Paper Volume 12, Issue 18 pp 18453—18475
A newly defined risk signature, consisting of three m6A RNA methylation regulators, predicts the prognosis of ovarian cancer
Figure 1. Workflow chart of data generation and analysis. The study mainly incorporated two sections: comprehensive bioinformatics analysis in 18 m6A RNA methylation regulators (including Spearman correlation analysis, protein-protein interaction analysis, consensus cluster analysis, cluster survival analysis and so on) and in the three selected m6A RNA methylation regulators (including CCLE database methylation analysis, protein-protein interaction network analysis, univariate Cox, multivariate Cox and so on).